Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-24-211469
Filing Date
2024-09-03
Accepted
2024-09-03 06:05:57
Documents
10
Period of Report
2024-08-30

Document Format Files

Seq Description Document Type Size
1 6-K d852554d6k.htm 6-K 9559
2 EX-99.1 d852554dex991.htm EX-99.1 1420058
3 GRAPHIC g852554dsp40.jpg GRAPHIC 6229
4 GRAPHIC g852554dsp97a.jpg GRAPHIC 19674
5 GRAPHIC g852554g0830093451765.jpg GRAPHIC 2002
6 GRAPHIC g852554g0830093452035.jpg GRAPHIC 3304
7 GRAPHIC g852554g0830093452366.jpg GRAPHIC 1911
8 GRAPHIC g852554g0830093452576.jpg GRAPHIC 2047
9 GRAPHIC g852554g0830093452757.jpg GRAPHIC 1285
10 GRAPHIC g852554g97a01.jpg GRAPHIC 29394
  Complete submission text file 0001193125-24-211469.txt   1522491
Mailing Address LEVEL 32, SUITE 32.07 AUSTRALIA SQUARE 264 GEORGE STREET SYDNEY, C3 NSW 2000
Business Address LEVEL 32, SUITE 32.07 AUSTRALIA SQUARE 264 GEORGE STREET SYDNEY, C3 NSW 2000 612 8315 7003
IMMUTEP Ltd (Filer) CIK: 0001506184 (see all company filings)

EIN.: 000000000 | State of Incorp.: C3 | Fiscal Year End: 0630
Type: 6-K | Act: 34 | File No.: 001-35428 | Film No.: 241271785
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)